PLGA nanoparticles delivering CPT-11 combined with focused ultrasound inhibit platinum resistant ovarian cancer

BACKGROUND: Ovarian cancer cells show resistance to platinum drugs treatment, which brings a big challenge to clinical therapeutics. This study aimed to construct effective drug delivering nanoparticles specifically targeting ovarian cancer cell. METHODS: Poly lactic-co-glycolic acid (PLGA) were use...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaogang, Yan, Siqi, Xiao, Fang, Xue, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797841/
https://www.ncbi.nlm.nih.gov/pubmed/35116498
http://dx.doi.org/10.21037/tcr-20-3171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797841/
https://www.ncbi.nlm.nih.gov/pubmed/35116498
http://dx.doi.org/10.21037/tcr-20-3171

Ejemplares similares